Acute Coronary Syndromes 2012
DOI: 10.5772/29572
|View full text |Cite
|
Sign up to set email alerts
|

Thrombotic Inception at Nano-Scale

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 82 publications
0
2
0
Order By: Relevance
“…Metallic NP-induced platelet aggregation is inhibited when ADP pathway is blocked by an appropriate concentration of clopidogrel or apyrase inhibiting therefore the secondary wave of platelet aggregation which depends mainly on granule release. GPIIbIIIa seems to play also an important role in metallic NP-induced platelet aggregation as in the presence of Arg-Gly-Asp-Ser (RGDS), a tetra-peptide which binds and inhibits activated but not resting GpIIbIIIa, platelet aggregation is attenuated (86).…”
Section: Metallic Nanoparticles-platelets Interactionsmentioning
confidence: 99%
“…Metallic NP-induced platelet aggregation is inhibited when ADP pathway is blocked by an appropriate concentration of clopidogrel or apyrase inhibiting therefore the secondary wave of platelet aggregation which depends mainly on granule release. GPIIbIIIa seems to play also an important role in metallic NP-induced platelet aggregation as in the presence of Arg-Gly-Asp-Ser (RGDS), a tetra-peptide which binds and inhibits activated but not resting GpIIbIIIa, platelet aggregation is attenuated (86).…”
Section: Metallic Nanoparticles-platelets Interactionsmentioning
confidence: 99%
“…(i) Thrombus imaging: Acute coronary syndrome (ACS) is one of the leading causes of death in the world 58 59 60 61 62 . Atherosclerotic plaques in humans consist of different bio-components which are heterogeneous in nature, i.e.…”
Section: Nanotechnology and Cardiovascular Diseasesmentioning
confidence: 99%